ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025GlobeNewsWire • 02/18/26
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025GlobeNewsWire • 01/08/26
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in FocusGlobeNewsWire • 01/07/26
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®GlobeNewsWire • 12/24/25
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin StrengthZacks Investment Research • 11/20/25
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025GlobeNewsWire • 11/13/25
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025GlobeNewsWire • 11/06/25
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025GlobeNewsWire • 08/14/25
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025GlobeNewsWire • 08/07/25
ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin GainsZacks Investment Research • 05/19/25